Get started
NATCO PHARMA LTD.NATCO PHARMA LTD.NATCO PHARMA LTD.

NATCO PHARMA LTD.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

NATCOPHARM trade ideas

Amazing breakout on Weekly / Daily Timeframe - NATCOPHARMCheckout an amazing breakout happened in the stock in Weekly timeframe, macroscopically seen in Daily timeframe. Having a great favour that the stock might be bullish expecting a staggering returns of minimum 25% TGT. IMPORTANT BREAKOUT LEVELS ARE ALWAYS RESPEECTED! NOTE for learners: Place the breakout levels as per the chart shared and track it yourself to get amazed!! #No complicated chart patterns #No big big indicators #No Excel sheet or number magics TRADE IDEA: WAIT FOR THE STOCK TO BREAKOUT IN LOWER TIMEFRAME AND RETRACE IF NEEDED. SL IS NEARER SUPPORT ZONE IN Daily TIMEFRAME. PS: No new Nifty500 script can escape from me when making a breakout. :-)
NSE:NATCOPHARMLong
by Yoyohoneysingh93
Natco Pharma: Sustained Breakout or Pullback Retest?Analysis: The chart of Natco Pharma Ltd. on TradingView depicts an intriguing post-breakout scenario, presenting both potential long entry and cautious approaches for traders. Let's dissect the situation: Current Price : ₹1026.50, well above the multi-year resistance level of ₹921.10 marked by the orange line. Breakout Confirmation: The recent surge past the resistance zone, accompanied by strong volume, confirms a potential trend reversal from resistance to support. Uptrend Momentum: The sustained price increase after the breakout indicates continued buying pressure, suggesting further upside potential. However, a crucial question arises: Has the breakout momentum exhausted, or is a pullback retest imminent? Aggressive: Option 1 (Immediate Long): Enter long if the price closes and sustains above the current level (₹1026.50) with persistent buying volume. This aggressive approach assumes the uptrend will continue. Option 2 (Breakout Confirmation): Enter long only if the price retests and decisively breaks above the breakout level (₹921.10) with renewed buying volume. This option waits for confirmation before committing. Conservative: Wait for Pullback: Wait for a potential pullback towards the breakout level (₹921.10) or within the previous consolidation zone (₹850-₹920). Enter long only if the price finds support at the pullback zone and exhibits bullish reversal signs (e.g., hammer candlestick pattern). This approach prioritizes minimizing risk by waiting for confirmation. Additional Considerations: The stock market is inherently volatile, and even confirmed breakouts can experience pullbacks. Conduct thorough fundamental research to assess Natco Pharma's financial health, industry outlook, and future prospects before making investment decisions. Implement prudent risk management through stop-loss orders and appropriate position sizing. Disclaimer: This analysis is for educational purposes only and should not be considered financial advice. Please conduct your own research before making any investment decisions.
NSE:NATCOPHARMLong
by TRADING-NASA
NATCO PHARMA - Bullish Consolidation Breakout with VolumesNSE: NATCOPHARM is closing with a bullish consolidation breakout candle supported with volumes. Today's volumes and candlestick formation indicates strong demand and stock should move to previous swing highs in the coming days. The stock has been moving along the horizontal support for the past few days which is indicating demand. One can look for a 12% to 18% gain on deployed capital in this swing trade. The view is to be discarded in the event of the stock breaking previous swing low. #NSEindia #Trading #StockMarketindia #Tradingview #SwingTrade
NSE:NATCOPHARMLong
by BrahmaBull31
Natco Pharma- A beautiful pattern mirroring!This will remain as one of my most favourite idea if breakout goes successful. Trade logic: An inverted head and shoulder breakout is on the cards. The most exciting and unique observation from this chart is that a similar IHNS breakout happened in 2021. But the breakout failed. However, the stock again has created an inverted head and shoulder pattern with the same neckline in a much lesser time compared to previous pattern. (4 years then vs 2.5 years now) Stock has cranked up its volume getting ready for a good breakout. Confirmation above 920. I wont be surprised if this stock breaches ATH levels if the breakout is successful. A good pharma stock from investment perspective as well. Keep in watchlist. Do like, comment and follow for such more ideas!
NSE:NATCOPHARMLong
by chartistamey
1
For the dreamers, the magic pill of Natco may be seen in 2024When things arent going your way, bend the chart and make the technicals prove your thesis! The monthly chart of Natco shows that its been travelling more or less within a parallel channel and is yet to complete an Impulse wave which began in 2002 and is most likely in the start of wave 5 (specifically completing wave 1 and undergoing corrective wave 2 of bigger degree wave 5) The good news? whenever the correction ends, a bull run may occur in Natco and the way things are stacked for the company, addressing the usfda problems in Kothur looks to be the trigger now as it has already demonstrated ability to earn super normal profits thorugh its policy of complex generics... how much lower the price will go is anyones guess....how high it can reach...well, there was not enough display space in my laptop to fit in the extension of parallel channel and show the max limit...lol! P.S. Wave 2 correction may be more severe if an Import Alert is issued to the Kothur plant .. most retail shareholders including myself may not be able to hold on if and when this occurs so tread knowingly
NSE:NATCOPHARMLong
by Rocky_Chow
Natco, always 2 steps forward and 1 step back Just when the profits of years of perseverance have begun rolling into the bank for Natco Pharma, the minority investors are in a spot of bother due to twin negative news of legal action in US pertaining to gRevlimid and the USFDA Form 483 with 8 observations during the Kothur plant inspection earlier in the month. The legal action is of lesser concern as the company has a marketing partner in US who most likely has to bear the legal costs, and there are well established laws regarding patents in the country. Kothur plant is only one of the 2 USFDA approved manufacturing plants for Natco and this plant is capable of manufacturing cytotoxic orals and injectibles. It is imperative for the company to get a clean chit in its follow up from the USFDA. The management of Natco has an impeccable track record and Kothur is their older USFDA approved plant which has been subject to audits from last many years. Meanwhile the share price has taken a beating after the most impressive quarterly performance in the companys history. In the long run price is a slave to earnings and with that adage one can take a position and look forward to the completion of an INHS in the making which may coincide with stellar Q2 numbers as guided by the mgmt in the Q1 concall. By the time Q4 results get declared we are looking at net profit of +1000 crores (management guidance) and this has a 50% probability of being bettered in the following year.
NSE:NATCOPHARMLong
by Rocky_Chow